Atlas Venture Life Science Advisors as of Dec. 31, 2025
Portfolio Holdings for Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors holds 8 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kymera Therapeutics Common Stock (KYMR) | 41.9 | $363M | 4.7M | 77.81 | |
| Dyne Therapeutics Common Stock (DYN) | 20.6 | $179M | 9.1M | 19.56 | |
| Sionna Therapeutics Common Stock (SION) | 14.2 | $123M | 3.0M | 41.14 | |
| Disc Medicine Common Stock (IRON) | 13.9 | $120M | 1.5M | 79.41 | |
| Day One Biopharmaceuticals Common Stock (DAWN) | 6.9 | $60M | 6.4M | 9.32 | |
| Korro Bio Common Stock (KRRO) | 1.1 | $9.1M | 1.1M | 8.01 | |
| Q32 Bio Common Stock (QTTB) | 0.8 | $6.9M | 2.1M | 3.32 | |
| Generation Bio Common Stock (GBIO) | 0.5 | $4.7M | 828k | 5.68 |
